STOCK TITAN

Saul Centers (NYSE: BFS) SVP Laycock gains 300 shares in equity awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Saul Centers, Inc. SVP and director Willoughby B. Laycock reported equity compensation activity in company stock. On March 11, 2026 he acquired 200 shares of Common Stock through exercises or conversions of performance-based awards and received a 100-share grant at $0.0000 per share. After these awards, he holds 4,370.068 Common shares directly, plus additional stock options, performance-based awards, phantom stock units and indirect holdings through a spouse’s 401(k), all of which are compensation-related and not open-market trades.

Positive

  • None.

Negative

  • None.
Insider Laycock Willoughby B.
Role SVP-Res. Design/Mrkt Research
Type Security Shares Price Value
Exercise Performance Shares 100 $0.00 --
Exercise Performance Shares 100 $0.00 --
Exercise Common Stock 200 $0.00 --
Grant/Award Common Stock 100 $0.00 --
holding Employee Stock Option -- -- --
holding Director Stock Option -- -- --
holding Employee Stock Option -- -- --
holding Director Stock Option -- -- --
holding Employee Stock Option -- -- --
holding Director Stock Option -- -- --
holding Employee Stock Option -- -- --
holding Director Stock Option -- -- --
holding Employee Stock Option -- -- --
holding Director Stock Option -- -- --
holding Phantom Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Performance Shares — 300 shares (Direct); Common Stock — 4,270.068 shares (Direct); Employee Stock Option — 5,000 shares (Direct); Director Stock Option — 2,500 shares (Direct); Phantom Stock — 4,169.46 shares (Direct); Common Stock — 249.952 shares (Indirect, Spouse-401K)
Footnotes (1)
  1. Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates. Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates. The options vest 25% per year over four years from the date of grant. Phantom shares are issuable pursuant to the Issuer's Deferred Compensation Plan for Directors under its 2004 Stock Plan, as amended (the "Deferred Compensation Plan"). Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service. The conversion of the phantom stock into shares of the Issuer's common stock is governed by the Deferred Compensation Plan and the reporting person's Deferred Fee Election Agreement. Includes 234.804 shares awarded July 31, 2025, October 31, 2025 and January 31, 2026 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Laycock Willoughby B.

(Last) (First) (Middle)
7501 WISCONSIN AVE.
SUITE 1400

(Street)
BETHESDA MD 20814

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SAUL CENTERS, INC. [ BFS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
SVP-Res. Design/Mrkt Research
3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 249.952 I Spouse-401K
Common Stock 03/11/2026 M 200(1) A $0 4,270.068 D
Common Stock 03/11/2026 A 100(2) A $0 4,370.068 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option $55.71 05/03/2019(3) 05/03/2029 Common Stock 5,000 5,000 D
Director Stock Option $55.71 05/03/2019 05/03/2029 Common Stock 2,500 2,500 D
Employee Stock Option $50 04/24/2020(3) 04/24/2030 Common Stock 10,000 10,000 D
Director Stock Option $50 04/24/2020 04/24/2030 Common Stock 2,500 2,500 D
Employee Stock Option $43.89 05/07/2021(3) 05/07/2031 Common Stock 10,000 10,000 D
Director Stock Option $43.89 05/07/2021 05/07/2031 Common Stock 2,500 2,500 D
Employee Stock Option $47.9 05/13/2022(3) 05/13/2032 Common Stock 10,000 10,000 D
Director Stock Option $47.9 05/13/2022 05/13/2032 Common Shares 2,500 2,500 D
Employee Stock Option $33.79 05/12/2023(3) 05/12/2033 Common Stock 10,000 10,000 D
Director Stock Option $33.79 05/12/2023 05/12/2033 Common Stock 2,500 2,500 D
Phantom Stock (4) (5) (5) Common Stock 4,169.46 4,169.46(6) D
Performance Shares $0 03/11/2026 M 100 05/17/2029 05/17/2029 Common Stock 100 $0 300 D
Performance Shares $0 03/11/2026 M 100 05/09/2030 05/09/2030 Common Stock 100 $0 400 D
Explanation of Responses:
1. Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.
2. Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.
3. The options vest 25% per year over four years from the date of grant.
4. Phantom shares are issuable pursuant to the Issuer's Deferred Compensation Plan for Directors under its 2004 Stock Plan, as amended (the "Deferred Compensation Plan"). Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service.
5. The conversion of the phantom stock into shares of the Issuer's common stock is governed by the Deferred Compensation Plan and the reporting person's Deferred Fee Election Agreement.
6. Includes 234.804 shares awarded July 31, 2025, October 31, 2025 and January 31, 2026 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.
Remarks:
/s/ Carlos L. Heard, by Power of Attorney 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Saul Centers (BFS) report for Willoughby B. Laycock?

Saul Centers reported that Willoughby B. Laycock acquired 300 Common shares on March 11, 2026. He received 200 shares through exercises or conversions of performance-based awards and a separate 100-share grant, all at a stated price of $0.0000 per share as equity compensation.

How many Saul Centers (BFS) shares does Willoughby B. Laycock hold after the latest Form 4?

Following the March 11, 2026 transactions, Willoughby B. Laycock directly holds 4,370.068 shares of Saul Centers Common Stock. This reflects the addition of 300 shares from performance-based award exercises and a grant, as reported, and excludes his separate derivative and phantom stock positions.

What performance-based and option awards does Willoughby B. Laycock retain in Saul Centers (BFS)?

Laycock retains multiple employee and director stock options and performance-based awards over Saul Centers Common Stock, with exercise prices between $33.7900 and $55.7100 and expirations from 2029 through 2033. These derivative positions remain outstanding alongside his direct share holdings reported in the Form 4.

How do Saul Centers (BFS) phantom stock units work for Willoughby B. Laycock?

Laycock holds phantom stock under Saul Centers’ Deferred Compensation Plan. Each phantom share is economically equivalent to one Common share and becomes payable in cash or stock upon his termination of service, according to his Deferred Fee Election Agreement and the plan’s governing terms.

Are the recent Saul Centers (BFS) Form 4 transactions open-market purchases or compensation awards?

The reported transactions are compensation-related awards rather than open-market trades. They include exercises or conversions of performance-based awards into Common Stock and a separate grant of restricted shares, all at a stated price of $0.0000 per share, reflecting equity compensation structures.

What vesting schedule applies to Willoughby B. Laycock’s new restricted and performance-based Saul Centers shares?

The filing states that half of certain restricted and performance-based Common shares vest on May 17, 2029 and the remaining half on May 9, 2030. Vesting requires Laycock’s continued employment with Saul Centers through each applicable vesting date.